For Immediate Release
Chicago, IL - October 20, 2015 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Adidas AG ( ADDYY ) and Bayer AG ( BAYRY ).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .
Here are highlights from Monday's Analyst Blog:
Is Canada's Election a Tell for the U.S.?
On Monday, keep your eyes on Canada's prime ministerial election.
For nearly a decade, the Conservatives' Stephen Harper has governed Canada. With collapsing oil prices , a recession and a series of scandals at hand, the majority of Canadians look for a big change after Monday's election. They voted early in record numbers.
In what has been the longest, most expensive campaign in modern Canada's history, a once tight three-way race shifted in favor of Justin Trudeau, leader of the center-left Liberal party. He is the son of revered former prime minister Pierre Trudeau.
As of October 15th, a Nanos poll showed the Liberals led polls with 37% support. The incumbent Conservatives trailed with 31%. The New Democratic Party scored 24%.
According to FT pundits in Canada, an "Obama effect" for Justin Trudeau buoyed the Liberals -- he represents youth, optimism and change. The Liberal party's relevance has waned over the last decade, after ruling Canada much of the past century.
Could Canada be a good tell for the forthcoming U.S. election? The call for change looks relevant to me. However, Canada has a recession on its hands. The U.S. doesn't.
In the U.S., a raft of Q3 earnings reports drives this Global Week Ahead.
So far, 20% of the S&P 500 companies reported. EPS topped forecasts by +3.4%. Revenues lag -0.3%.
It's that combination which is worrisome. Big companies are using share buybacks and accounting gimmicks to boost EPS growth, while revenue growth flat-lines.
Also, keep an eye on Europe. Mario Draghi hits newswires with a new ECB statement on Thursday.
Up-staged QE moves out of Europe's Central bank would be 'new' news.
For fresh Zacks #1 Rank European stocks, take a look at the Adidas AG ( ADDYY ), the global Shoe & Apparel Company.
Shares put in a shallow second bottom in early September. They have been rising since. The PEG valuation ratio at 1.52 looks solid.
In Germany, too, look into Bayer AG ( BAYRY ). This Drug industry stock has also scored a fresh Zacks #1 Rank.
The Drug industry's overall rank is high at number 28 out of 265. The stock's Momentum rank is A, with a Value rank of B. Bayer shares sold off recently, along with nearly all Drug stocks.
The China GDP number out of Monday was a beat. But there was little positive reaction from Asian markets. I expect Asian stock investors are waiting for actual stimulus from the Mainland Chinese government to act as a catalyst.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today . Find out What is happening in the stock market today on zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ADIDAS AG-ADR (ADDYY): Free Stock Analysis Report
BAYER A G -ADR (BAYRY): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
